# Momus PRD Review: strategy-recommendation

**Date:** 2026-05-31
**Artifacts reviewed:** PRD: `.sisyphus/prds/strategy-recommendation-prd.md`

## Summary

**Gate Decision:** PASS
**Blocker count:** 0 total (0 critical, 0 major, 0 minor)

### Top 3 Risks
1. **Test profile availability** — The 5 test targets listed in Testing Decisions (sinahatami.vercel.app, advanced-team-clone, etc.) must be available and produce expected results. If a target changes or goes offline, integration tests break.
2. **Auth signal gap** — D4 defers auth detection. Auth-gated SPA sites may be misclassified as Static Export (the auth gate prevents JavaScript execution). Mitigation (documented in R2): AMBIGUOUS confidence handles edge cases.
3. **Effort calibration** — Small/Medium/Large labels are heuristic-based with no historical data. Risk of misleading users if effort labels don't match actual clone complexity.

## Detailed Findings

### A. Logical Contradictions

None found. All decisions are internally consistent:
- "No new detection passes" is preserved — signals reference existing sections only
- Auth signal is present in the matrix but flagged as deferred (D4) — scored as 0, documented behavior
- Additive constraint is maintained — existing output formats unchanged
- Section 22 is text-only — no UI scope creep

### B. Scope Creep

None found. The feature is well-bounded:
- All 6 user stories map directly to 1 of 4 slices in the First Execution Wave
- No hidden infrastructure dependencies (no databases, APIs, or services)
- No modifications to Phase 1–5 pipeline required
- Auth detection explicitly deferred to v2.1
- Day-count effort estimates explicitly out of scope

### C. Missing Verification

No blockers. Acceptance criteria are well-defined:

- US-1: "≥8 signal keys with numeric values" — specific, testable
- US-2: Numeric scores per category, confidence formula — specific, testable
- US-3: "JSON configuration object" — testable by inspection
- US-4: "≥5 subsections in Section 22" — testable by inspection
- US-5: "line `**Strategy:** ...` in analysis-summary.md" — specific, testable
- US-6: References existing validation scripts — testable (note: these scripts test runtime analysis, not the full pipeline; consider adding a dedicated `validate-strategy.js` for the strategy feature)

## Fix Recommendations (Priority Order)

None required. All acceptance criteria are specific, testable, and free of subjective language.

**Optional improvement (non-blocking):** Add a dedicated `validate-strategy.js` validation script in the Testing Decisions section to make US-6 more directly verifiable.
